garagehelmet9
About
Etrolizumab compared to infliximab for the relatively to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, cycle 3 research.
Etrolizumab compared to infliximab for the relatively to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, cycle 3 research.